Publications by authors named "Julie Raillat"
Article Synopsis
- Surgical resection and chemotherapy are the main treatments for localized pancreatic ductal adenocarcinoma (LPDAC), but most patients experience recurrence, highlighting the need for improved preoperative therapy assessments.
- A study at Besancon University Hospital analyzed factors from 146 LPDAC patients to predict relapse-free survival (RFS), focusing on immunological and nutritional elements.
- It found that preoperative lymphopenia (low lymphocyte count) and sarcopenia (low muscle mass) significantly impact RFS, allowing for the classification of patients into three risk groups with varied survival outcomes.
